Advance Search
WANG Jinxia, WANG Juxin, LIU Jing, GENG Chang. Effect of Yiqi Tongluo Anshen Recipe combined with statins on coronary blood flow and blood pressure in patients with coronary heart disease and hypertension[J]. Journal of Clinical Medicine in Practice, 2023, 27(23): 43-46, 53. DOI: 10.7619/jcmp.20233055
Citation: WANG Jinxia, WANG Juxin, LIU Jing, GENG Chang. Effect of Yiqi Tongluo Anshen Recipe combined with statins on coronary blood flow and blood pressure in patients with coronary heart disease and hypertension[J]. Journal of Clinical Medicine in Practice, 2023, 27(23): 43-46, 53. DOI: 10.7619/jcmp.20233055
shu

Effect of Yiqi Tongluo Anshen Recipe combined with statins on coronary blood flow and blood pressure in patients with coronary heart disease and hypertension

  • 1.

    Outpatient Department on Fuxue Road of Jingdong Medical District, General Hospital of People's Liberation Army, Beijing, 102200

  • 2.

    Department of Cardiovascular Disease, Beijing Changping District Hospital of Traditional Chinese Medicine, Beijing, 102200

  • 3.

    Department of Encephalopathy, Beijing Changping District Hospital of Traditional Chinese Medicine, Beijing, 102200

More Information
  • Received Date: September 24, 2023
  • Revised Date: November 02, 2023
  • Available Online: December 25, 2023
    Graphical Abstract
    • Abstract
  • Objective 

    To explore the effect of Yiqi Tongluo Anshen Recipe combined with statins on coronary blood flow and blood pressure in patients with coronary heart disease complicated with hypertension.

    Methods 

    A total of 120 patients with coronary heart disease combined with hypertension were selected as study objects, and were divided into two groups according to treatment methods, with 60 patients in each group. The conventional group was treated with amlodipine tablets combined with atorvastatin calcium tablets, and the Anshen prescription group was treated with Yiqi Tongluo Anshen Recipe on the basis of the conventional group. The levels of Salusin-β, lipoprotein-associated phospholipase A2 (LP-PLA2), high-sensitivity C-reactive protein (hs-CRP), pentamylin 3 (PTX3), tumor necrosis factor-α (TNF-α) and blood pressure of the two groups were recorded before and after treatment, and the TIMI3 rate of coronary blood flow in myocardial infarction thrombolysis test (TIMI) and the adverse reaction rate during treatment were analyzed.

    Results 

    The total effective rate of TCM syndrome in the Anshen prescription group was higher than that in conventional group (P < 0.05). After treatment, systolic blood pressure (SBP) and diastolic blood pressure (DBP) in two groups were lower than before treatment, and SBP and DBP in the Anshen prescription group were lower than those in the conventional group (P < 0.05). The rate of coronary blood flow TIMI3 in the Anshen prescription group was higher than that in the conventional group (P < 0.05). After treatment, levels of Salusin-β, LP-PLA2, PTX3, hs-CRP and TNF-α in two groups were decreased compared with those before treatment, and levels of Salusin-β, LP-PLA2, PTX3, hs-CRP and TNF-α levels of in the Anshen prescription group after treatment were lower than those in the conventional group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the Anshen prescription group and the conventional group (P>0.05).

    Conclusion 

    Yiqi Tongluo Anshen Recipe combined with statins in the treatment of coronary heart disease with hypertension can reduce the expression of related factors, improve coronary blood flow and the curative effect.

    • FullText(HTML)
    • References (24)
  • [1]
    胡金明, 钟萍. 高血压患者冠状动脉微循环损伤研究进展[J]. 实用医院临床杂志, 2020, 17(5): 234-236. https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC202005072.htm
    [2]
    COLANGELO L A, YANO Y, JACOBS D R J, et al. Association of resting heart rate with blood pressure and incident hypertension over 30 years in black and white adults[J]. Hypertension, 2020, 76(3): 692-698. doi: 10.1161/HYPERTENSIONAHA.120.15233
    [3]
    朱苗苗, 高永翔. 冠心病中医病因病机认识[J]. 中西医结合心脑血管病杂志, 2017, 15(11): 1336-1339. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201711013.htm
    [4]
    周慎, 刘祖贻. 国医大师刘祖贻治疗冠心病经验[J]. 湖南中医药大学学报, 2017, 37(1): 1336-1339. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZX201701002.htm
    [5]
    葛均波, 徐永健. 内科学[M]. 8版. 北京: 人民卫生出版社, 2013: 227. 162.
    [6]
    中国高血压病防治指南修订委员会. 中国高血压病防治指南2010[J]. 中华心血管病杂志, 2011, 40(8): 701-743. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201611024.htm
    [7]
    中国中西医结合学会活血化瘀专业委员会. 血瘀证中西医结合诊疗共识[J]. 中国中西医结合杂志, 2011, 31(6): 839-844. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201106037.htm
    [8]
    郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 143-145.
    [9]
    TERAMOTO K, NADRUZ JUNIOR W, MATSUSHITA K, et al. Mid- to late-life time-averaged cumulative blood pressure and late-life cardiac structure, function, and heart failure[J]. Hypertension, 2020, 76(3): 808-818. doi: 10.1161/HYPERTENSIONAHA.120.14833
    [10]
    陈晨, 王妮, 黄艳群, 等. 基于居民健康大数据的肥胖与常见慢病关联规则分析[J]. 北京生物医学工程, 2020, 39(4): 406-411, 417. https://www.cnki.com.cn/Article/CJFDTOTAL-BJSC202004011.htm
    [11]
    张磊, 薛礼, 刘瑶, 等. 动态血压参数与冠状动脉病变严重程度的相关性研究[J]. 蚌埠医学院学报, 2020, 45(9): 1211-1216. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG202009020.htm
    [12]
    冯妍, 王以新, 马涵英, 等. 冠状动脉粥样硬化性心脏病心力衰竭不同兼症及合并病中医治疗方案优化研究[J]. 中国医药, 2020, 15(8): 1192-1196. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202008010.htm
    [13]
    何蕾. 瓜蒌夏苓汤治疗冠心病稳定型心绞痛痰阻心脉证的临床效果[J]. 中国医药导报, 2020, 17(21): 153-156. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202021040.htm
    [14]
    程坤, 张军平. 国医大师阮士怡治疗胸痹心痛之经验撷要[J]. 江苏中医药, 2018, 50(5): 14-16. https://www.cnki.com.cn/Article/CJFDTOTAL-JSZY201805008.htm
    [15]
    傅姣慧, 谢雪姣. 从太阳和少阳病的角度论治胸痹[J]. 环球中医药, 2020, 13(8): 1428-1430. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202008035.htm
    [16]
    邵笑, 邓悦. 气血津液理论在心血管疾病中的应用研究进展[J]. 中西医结合心脑血管病杂志, 2020, 18(17): 2801-2803. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202017011.htm
    [17]
    董辉, 王凤荣. 中西医结合疗法对胸痹心痛寒凝血瘀证失眠患者的疗效观察[J]. 世界中西医结合杂志, 2020, 15(6): 1076-1079. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX202006023.htm
    [18]
    黄溥玮, 卢健棋, 黎炯彤, 等. 中医药治疗气虚血瘀型不稳定型心绞痛的研究进展[J]. 中西医结合心脑血管病杂志, 2020, 18(13): 2084-2086. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202013016.htm
    [19]
    张晓琦, 宋耀鸿, 姜艳, 等. 从"瘀热论" 治疗冠心病[J]. 中西医结合心脑血管病杂志, 2020, 18(13): 2172-2174. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202013041.htm
    [20]
    李轶男, 王萍, 陈晖. Salusin-β与冠状动脉粥样硬化性心脏病的关系[J]. 中国心血管杂志, 2019, 24(6): 583-586. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG201906027.htm
    [21]
    朱国栋, 徐林, 李锋. 血清LP-PLA2、NEFA水平与冠状动脉病变严重程度的关系[J]. 中国医药导报, 2020, 17(20): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202020018.htm
    [22]
    胡海杰, 张艳. PTX3与疾病相关性的研究分析[J]. 西南国防医药, 2020, 30(5): 468-470. https://www.cnki.com.cn/Article/CJFDTOTAL-XNGF202005035.htm
    [23]
    艾民, 乔玉花, 张思艺. 血清超敏C反应蛋白白介素6与冠状动脉病变程度的相关性[J]. 安徽医学, 2020, 41(9): 1013-1016. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYX202009008.htm
    [24]
    贺正波, 束晨, 张明玺. 氨氯地平联合阿托伐他汀钙片对高血压合并冠心病病人免疫功能、血管内皮功能与炎症因子水平的影响[J]. 中西医结合心脑血管病杂志, 2020, 18(8): 1276-1279. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202008025.htm
    • Related Articles

  • Related Articles

    [1]FANG Zhiqin, LIANG Huiqing, ZHANG Pengxiang, ZHAO Kun, MA Yiping, WANG Yaling, LI Fangjiang, LI Jun, LI Pingping. Effect of nicorandil combined with rosuvastatin calcium in treatment of patients with slow coronary flow[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 70-75. DOI: 10.7619/jcmp.20241838
    [2]LI Jinpei, WANG Yonghuai, LI Guangyuan, MA Chunyan, YANG Jun. Research progress on risk factors of coronary slow flow[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 115-118. DOI: 10.7619/jcmp.20220353
    [3]CAO Li, XU Baida, YE Ting, LIU Jie, AN Dongmei. Correlation between gender difference and impaired coronary flow reserve in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 43-46. DOI: 10.7619/jcmp.20215085
    [4]ZHANG Zhu, FAN Xiucai, LIU Pingang, TAO Liangliang. Value of thromboelastography in analyzing blood hypercoagulability and ischemic events after percutaneous coronary intervention in coronary heart disease patients with anti-platelet drug therapy[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 43-46. DOI: 10.7619/jcmp.20213934
    [5]LIU Siping, LI Delong, WANG Xingdong, WANG Daocheng, LI Xiang, MAO Haiyan. Correlations between TCM syndromes of coronary heart disease and body mass index, levels of blood lipid as well as manifestations of coronary CT angiography[J]. Journal of Clinical Medicine in Practice, 2021, 25(15): 60-64. DOI: 10.7619/jcmp.20211338
    [6]ZHOU Yongfeng, DANG Weili. Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 100-102. DOI: 10.7619/jcmp.202014027
    [7]QIU Min, XU Shaohua, JIANG Hai, LONG Mingzhi. Changes of lipoprotein-associated phospholipase A2 and high sensitivity C reactive protein in patients with coronary slow flow[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 29-32. DOI: 10.7619/jcmp.201910009
    [8]XIAO Ru'nan. Efficacy of nursing intervention in the treatment of amlodipine and atorvastatin calcium tablet for patients with hypertension combined with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2017, (4): 1-3,7. DOI: 10.7619/jcmp.201704001
    [9]JU Yanling, ZANG Xuelian, ZHAO Xu. Effect of amlodipine atorvastatin calcium tablet on IMT, PV, TNF, CRP, and blood lipid level of coronary heart disease and high blood pressure patients complicated with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2017, (1): 14-18. DOI: 10.7619/jcmp.201701004
    [10]MENG Xiaofeng, SUI Shihua, SU Hao. Comparison in therapeutic effects and prognosis of interventional therapy in coronary heart disease patients with different blood glucose levels[J]. Journal of Clinical Medicine in Practice, 2016, (13): 1-4. DOI: 10.7619/jcmp.201613001

  • Cited by

    Periodical cited type(4)

    1. 邱彩虹. 中医心脏康复护理技术在高血压伴冠心病稳定型心绞痛患者中的应用. 心血管病防治知识. 2024(13): 118-121 .
    2. 陆向阳. 氨氯地平联合阿托伐他汀钙片治疗高血压合并冠心病的效果分析. 中国实用医刊. 2024(22): 95-98 .
    3. 罗雪文. 补阳还五汤加减、丹红注射液联合阿托伐他汀治疗对高血压合并脑梗死患者的疗效及血管内皮功能影响. 心血管病防治知识. 2024(19): 34-37 .
    4. 李瑞华. 氨氯地平联合他汀类药物对高血压患者颈动脉内膜中层厚度的影响. 黑龙江中医药. 2024(05): 71-73 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (122) PDF downloads (18) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return